Core Lab Reports Second Quarter 2019 Results From Continuing Operations:

Go back to Core Lab Reports Second Quarter 2019 Results From Continuing Operations:

Core Laboratories (CLB) Tops Q2 EPS by 1c, Revenues Miss; Q3 EPS Mid-Point Guidance Below Consensus, Q3 Rev. Outlook Below Consensus

July 24, 2019 5:43 PM EDT

Core Laboratories (NYSE: CLB) reported Q2 EPS of $0.46, $0.01 better than the analyst estimate of $0.45. Revenue for the quarter came in at $169 million versus the consensus estimate of $173.58 million.

Advanced laboratory analysis continues on conventional core from the Zama-2DEL ST-01 well and will... More